Sage Therapeutics, Inc. (SAGE) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-07-11
08:49 am
Purchase
2022-07-0813GSAGE THERAPEUTICS INC
SAGE
FMR LLC5,977,093
10.119%
486,519increase
(+8.86%)
Filing
History
2022-02-11
4:36 pm
Purchase
2021-12-3113GSAGE THERAPEUTICS INC
SAGE
BB BIOTECH AG3,170,104
5.400%
210,000increase
(+7.09%)
Filing
History
2022-02-10
08:37 am
Sale
2021-12-3113GSAGE THERAPEUTICS INC
SAGE
The Vanguard Group4,578,241
7.770%
-20,874decrease
(-0.45%)
Filing
History
2022-02-09
10:24 am
Sale
2022-02-0813GSAGE THERAPEUTICS INC
SAGE
FMR LLC5,490,574
9.320%
-188,697decrease
(-3.32%)
Filing
History
2022-02-04
09:22 am
Purchase
2021-12-3113GSAGE THERAPEUTICS INC
SAGE
Wellington Management Group LLP7,126,411
12.100%
999,731increase
(+16.32%)
Filing
History
Goto Prev, 0, 1, 2